Cargando…
Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium
Human pluripotent stem cells (hPSCs) are a promising source of autologous endothelial progenitor cells (EPCs) that can be used for the treatment of vascular diseases. However, this kind of treatment requires a large amount of EPCs. Therefore, a highly efficient, robust, and easily reproducible diffe...
Autores principales: | Farkas, Simon, Simara, Pavel, Rehakova, Daniela, Veverkova, Lenka, Koutna, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249886/ https://www.ncbi.nlm.nih.gov/pubmed/32509776 http://dx.doi.org/10.3389/fcell.2020.00309 |
Ejemplares similares
-
Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells
por: Simara, Pavel, et al.
Publicado: (2018) -
DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing
por: Simara, Pavel, et al.
Publicado: (2017) -
The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells
por: Salingova, Barbara, et al.
Publicado: (2019) -
The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture
por: Tesarova, Lenka, et al.
Publicado: (2016) -
Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy
por: Rehakova, Daniela, et al.
Publicado: (2020)